Malignant lymphoma in the dog is frequently postulated and used as a t
herapeutic model for non-Hodgkin's lymphoma (NHL) in humans. In this s
tudy DNA ploidy and the cell kinetic characteristics of canine maligna
nt lymphoma were studied by flow cytometric (FCM) nuclear DNA measurem
ents on fresh frozen tumor tissue from 94 dogs with NHL and on materia
l from non-neoplastic lymph nodes from 20 dogs. The results were corre
lated with histomorphology, immunophenotype and survival. All non-neop
lastic tissues were diploid, whereas of the 94 lymphomas 74 were diplo
id or near-diploid and 20 aneuploid. Of the aneuploid lymphomas, 1 con
tained a hypoploid cell population. DNA indices of the aneuploid peaks
ranged from 0.87 to 1.21 (mean 1.11). The mean S-phase fraction (8.2%
, SD 4.8) was significantly lower in the non-neoplastic tissues than i
n the lymphomas (11.4%, SD 5.1). A linear correlation was observed bet
ween ECM S-phase fractions and bromodeoxyuridine (BrdU) labeling indic
es (r=0.78; p<0.001) determined in paraffin-embedded tissue sections f
rom 18 dogs with NHL after in vivo BrdU labeling. DNA ploidy status di
d not correlate to the S-phase fraction. There were no differences in
S-phase fraction and DNA ploidy between B cell and T cell lymphomas or
between different histological classes using the Working Formulation.
No correlation was found between S-phase fraction or DNA ploidy and s
urvival in a series of 59 dogs treated with a combination chemotherapy
protocol. It is concluded that the frequency of DNA aneuploidy in can
ine malignant lymphoma is similar to that in human NHL. In contrast to
findings in human NHL, however, no relationship was found between DNA
ploidy or cell kinetic features and histomorphology or prognosis.